Study of blood rheological parameters and NO in coronary artery disease patients with and without collaterals

Maia Chigogidze1, Maia Mantskava2,3, Tamar Sanikidze4

  • 1Faculty of Medicine, Ivane Javakhishvili Tbilisi State University. Tbilisi, Georgia.

Insights

In coronary artery disease (CAD), reduced nitric oxide (NO) and increased erythrocyte aggregation impair blood flow and collateral development. Lower NO levels correlate with fewer developed collaterals, impacting angiogenesis.

Area of Science:

  • Cardiovascular Medicine
  • Rheology
  • Molecular Biology

Background:

  • Coronary artery disease (CAD) involves impaired blood flow to the myocardium.
  • Coronary collateral circulation offers an alternative pathway for blood supply in ischemic areas.
  • Understanding factors influencing collateral development is crucial for managing CAD.

Purpose of the Study:

  • To investigate blood rheological parameters and nitric oxide (NO) levels in CAD patients.
  • To correlate rheological factors and NO content with the degree of collateral development.
  • To explore the influence of blood fluidity on collateral angiogenesis in CAD.

Main Methods:

  • Study included patients with stable CAD undergoing coronary angiography and a control group.
  • Assessed blood rheology: plasma viscosity, erythrocyte aggregability, and deformability.
  • Measured stable metabolic end products of nitric oxide (NOx).

Main Results:

  • CAD patients exhibited increased erythrocyte aggregation and decreased NO levels compared to controls.
  • A significant inverse correlation was observed between NO content and the number of developed collaterals.
  • Lower NO levels were associated with less developed collateral circulation.

Conclusions:

  • Erythrocyte aggregation and endothelial nitric oxide (NO) play roles in regulating angiogenesis in CAD.
  • These factors may be involved in direct and feedback mechanisms of collateral development.
  • Findings highlight the importance of rheological properties and NO in CAD pathophysiology.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
129
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
18
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
15
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
212
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
39